id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-N-3326-0001,FDA,FDA-2015-N-3326,Biosimilar User Fee Act; Public Meeting,Notice,Meeting,2015-09-28T04:00:00Z,2015,9,2015-09-28T04:00:00Z,2016-01-20T04:59:59Z,2016-01-20T22:00:42Z,2015-24524,0,0,0900006481c9dc5e